19.1. Analysis.

Comparison 19: Safety: demyelinating diseases ‐ multiple sclerosis ‐ acute disseminated encephalomyelitis, Outcome 1: Case‐control

Comparison 19: Safety: demyelinating diseases ‐ multiple sclerosis ‐ acute disseminated encephalomyelitis, Outcome 1: Case‐control